AstraZeneca unit sued over alleged monopoly on blockbuster drug Soliris AstraZeneca's Alexion Pharmaceuticals was sued in Massachusetts federal court on Wednesday in a class action complaint ...

DUBAI, UAE – Media OutReach Newswire – 28 January 2025 – AstraZeneca, a leading multinational pharmaceutical and biotechnology company, has been recognized as the second-best place to work across the ...

We’ve got you covered with the Den of Geek 2025 TV Premiere Dates Calendar, where we keep track of TV series premiere dates, return dates, and more for the year and beyond. We’ll continue to ...

AstraZeneca saw its share price decline by 3.5% in the last quarter, a period marked by several key developments, including the European approval of DATROWAY for breast cancer treatment and ...

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

Tech giant Apple (AAPL) lost its title as the world's most valuable listed company on Tuesday, after shares in the iPhone maker slid 5% amid volatility around tariffs. The fall in Apple's (AAPL) ...

You can use the Apple Calendars app to create a shared calendar for your family. To create a family calendar, open the Calendar app, tap Calendars, and select Add Calendar. Share the newly-created ...

Wake County's year-round schools with multiple tracks aren't doing better academically than traditional-calendar schools, when adjusted for demographics or other school characteristics ...

Nearly 60,000 Australians ventured outside in October 2024 to take part in the Aussie Bird Count, the country’s largest citizen science event. More than 4.1 million birds were counted in the 2024 ...

We announced the 24 innovative companies that pitched their technologies to the competition’s panel of judges at the final on 4 July 2024. The finalists were selected from a competitive application ...

NSCLC is the most prevalent form of lung cancer. Credit: Jo Panuwat D/Shutterstock. The European Commission (EC) has granted approval for AstraZeneca’s Imfinzi plus chemotherapy for treating ...